-+ 0.00%
-+ 0.00%
-+ 0.00%

*Pulmatrix Has Stopped Patient Enrollment for Phase 2b Study of PUR1900 While Cipla Has Continued Their Phae 2 Trial Outside U.S. >PULM

Dow Jones·03/21/2025 12:06:00

Please log in to view news